Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Composition and Metabolic Activity of Gut Microbiota to Predict Early Inflammatory Bowel Disease Progression

NCT06756100 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT06756100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06756100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Composition and Metabolic Activity of Gut Microbiota to Predict Early Inflammatory Bowel Disease Progression
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Observational
Overall status
Recruiting
Start date
July 7, 2023
Completion date
April 30, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), inflammatory bowel diseases, ulcerative colitis (uc)